Depósito Digital de Documentos de la UAB Encontrados 3 registros  La búsqueda tardó 0.01 segundos. 
1.
10 p, 396.0 KB Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events : The ODYSSEY OUTCOMES Trial / Szarek, Michael (State University of New York) ; White, Harvey D. (University of Auckland and Green Lane Cardiovascular Services Auckland City Hospital) ; Schwartz, Gregory G. (Division of Cardiology. University of Colorado School of Medicine) ; Alings, Marco (Amphia Ziekenhuis Molengracht) ; Bhatt, Deepak L (Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School) ; Bittner, Vera A. (University of Alabama at Birmingham) ; Chiang, Chern-En (Taipei Veterans General Hospital and National Yang-Ming University) ; Diaz, Rafael (Instituto Cardiovascular de Rosario) ; Edelberg, Jay M. (Sanofi) ; Goodman, Shaun G. (University of Toronto) ; Hanotin, Corinne (Sanofi) ; Harrington, R.A. (Stanford University) ; Jukema, J.Wouter (Leiden University Medical Center) ; Kimura, Takeshi (Kyoto University Graduate School of Medicine) ; Kiss, Robert Gabor (Magyar Honvédség Egészségügyi Központ) ; Lecorps, Guillaume (Sanofi) ; Mahaffey, Kenneth W. (Stanford University) ; Moryusef, Angèle (Sanofi) ; Pordy, Robert (Regeneron Pharmaceuticals Inc.) ; Roe, Matthew T. (Duke University Medical Center) ; Tricoci, Pierluigi (Duke University Medical Center) ; Xavier, Denis (St. John's Medical College and Research Institute) ; Zeiher, Andreas Michael (Goethe University) ; Steg, Ph Gabriel (Royal Brompton Hospital (Londres)) ; Cequier Fillat, Angel R. (Hospital Universitari de Bellvitge) ; Garcia-Dorado, David (Hospital Universitari Vall d'Hebron) ; Matas Pericas, Laia (Institut d'Investigació Biomèdica Sant Pau) ; Bruguera Cortada, Jordi (Hospital del Mar (Barcelona, Catalunya)) ; Gusi Tragant, Gabriel (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ; Coca Payeras, Antonio (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or maximum-tolerated statin treatment, after acute coronary syndrome (ACS) in 18,924 patients. [...]
2019 - 10.1016/j.jacc.2018.10.039
Journal of the American College of Cardiology, Vol. 73 Núm. 4 (may 2019) , p. 387-396  
2.
8 p, 1.1 MB Temperature dependent local atomic displacements in ammonia intercalated iron selenide superconductor / Paris, E. (Istituto Italiano di Tecnologia) ; Simonelli, Laura (ALBA Laboratori de Llum de Sincrotró) ; Wakita, Takanori (Okayama University) ; Marini, Carlo (ALBA Laboratori de Llum de Sincrotró) ; Lee, J. H. (Okayama University) ; Olszewski, Wojciech (University of Bialystok) ; Terashima, Kensei (Okayama University) ; Kakuto, Takeshi (Okayama University) ; Nishimoto, N. (Okayama University) ; Kimura, T. (Okayama University) ; Kudo, Kazutaka (Okayama University) ; Kambe, Takashi (Okayama University) ; Nohara, Minoru (Okayama University) ; Yokoya, Takayoshi (Okayama University) ; Saini, Naurang L. (Sapienza Universitá di Roma)
Recently, ammonia-thermal reaction has been used for molecular intercalation in layered FeSe, resulting a new Li x (NH 3) y Fe 2 Se 2 superconductor with T c ∼ 45 K. Here, we have used temperature dependent extended x-ray absorption fine structure (EXAFS) to investigate local atomic displacements in single crystals of this new superconductor. [...]
2016 - 10.1038/srep27646
Scientific reports, Vol. 6 (June 2016) , art. 27646  
3.
9 p, 252.4 KB El tono HLH* : una señal perceptiva que indica un límite / Kimura, Takuya (Seisen University (Tokyo, Japó)) ; Sensui, Hirotaka (Waseda University (Tokyo, Japó)) ; Takasawa, Miyuki (Waseda University (Tokyo, Japó)) ; Toyomaru, Atsuko (Kyoritsu University (Tokyo, Japó))
2008
Language design : journal of theoretical and experimental linguistics, Special Issue (2008) , p. 73-81  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.